Pure Global

Beckman Coulter IO detects CD3-FITC/Anti-HLA-DR-PE monoclonal antibodies - Taiwan Registration 18a6fab444804af8e22eb0be55233694

Access comprehensive regulatory information for Beckman Coulter IO detects CD3-FITC/Anti-HLA-DR-PE monoclonal antibodies in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 18a6fab444804af8e22eb0be55233694 and manufactured by IMMUNOTECH SAS, A BECKMAN COULTER COMPANY. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
18a6fab444804af8e22eb0be55233694
Registration Details
Taiwan FDA Registration: 18a6fab444804af8e22eb0be55233694
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Beckman Coulter IO detects CD3-FITC/Anti-HLA-DR-PE monoclonal antibodies
TW: ่ฒๅ…‹ๆ›ผๅบซ็ˆพ็‰นIOๆชขๆธฌCD3-FITC/Anti-HLA-DR-PE ๅ–ฎๆ ชๆŠ—้ซ”
Risk Class 2

Registration Details

18a6fab444804af8e22eb0be55233694

DHA00601754708

Company Information

Product Details

This fluorescently calibrated antibody cocktail is suitable for multiplex analysis using flow cytometry. It allows detection of CD3 and HLA-DR antigen manifestations on white blood cells.

B Hematology, pathology, and genetics

B.5220 Automatic Differentiation Cell Counter

import

Dates and Status

Sep 29, 2006

Sep 29, 2026